These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10764718)

  • 1. Long term effect of alpha interferon in children with chronic hepatitis B.
    Bortolotti F; Jara P; Barbera C; Gregorio GV; Vegnente A; Zancan L; Hierro L; Crivellaro C; Vergani GM; Iorio R; Pace M; Con P; Gatta A
    Gut; 2000 May; 46(5):715-8. PubMed ID: 10764718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hepatitis B infection: long term comparison of children receiving interferon alpha and untreated controls.
    Vo Thi Diem H; Bourgois A; Bontems P; Goyens P; Buts JP; Nackers F; Tonglet R; Sokal EM
    J Pediatr Gastroenterol Nutr; 2005 Feb; 40(2):141-5. PubMed ID: 15699686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of interferon-alpha treatment in children with hepatitis B e antigen-positive chronic hepatitis B virus infection: a meta-analysis of follow-up for six months to two years].
    Lin ZQ; Fang F; Guo ZF; Chen Q
    Zhonghua Er Ke Za Zhi; 2007 Aug; 45(8):592-8. PubMed ID: 18021533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term effect of treatment with interferon-alpha 2a in chronic hepatitis B. The Long-Term Follow-up Investigator Group. The European Study Group on Viral Hepatitis (EUROHEP). Executive Team on Anti-Viral Treatment.
    Krogsgaard K
    J Viral Hepat; 1998 Nov; 5(6):389-97. PubMed ID: 9857348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of alpha-interferon treatment of patients with chronic hepatitis B.
    van Zonneveld M; Honkoop P; Hansen BE; Niesters HG; Darwish Murad S; de Man RA; Schalm SW; Janssen HL
    Hepatology; 2004 Mar; 39(3):804-10. PubMed ID: 14999700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha treatment in children and young adults with chronic hepatitis B: a long-term follow-up study in Taiwan.
    Hsu HY; Tsai HY; Wu TC; Chiang CL; Ni YH; Chen PJ; Chang MH
    Liver Int; 2008 Nov; 28(9):1288-97. PubMed ID: 18397229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained HBeAg and HBsAg loss after long-term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b.
    Buster EH; Flink HJ; Cakaloglu Y; Simon K; Trojan J; Tabak F; So TM; Feinman SV; Mach T; Akarca US; Schutten M; Tielemans W; van Vuuren AJ; Hansen BE; Janssen HL
    Gastroenterology; 2008 Aug; 135(2):459-67. PubMed ID: 18585385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term follow-up of hepatitis B carrier children treated with interferon and prednisolone.
    Boxall EH; Sira J; Ballard AL; Davies P; Kelly DA
    J Med Virol; 2006 Jul; 78(7):888-95. PubMed ID: 16721856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pegylated-interferon alpha therapy for treatment-experienced chronic hepatitis B patients.
    Yeh ML; Peng CY; Dai CY; Lai HC; Huang CF; Hsieh MY; Huang JF; Chen SC; Lin ZY; Yu ML; Chuang WL
    PLoS One; 2015; 10(4):e0122259. PubMed ID: 25835020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased ratio of CD4/CD8 lymphocytes might be predictive for successful interferon alpha and lamivudine combined therapy in childhood chronic hepatitis B infection: A preliminary study.
    Genel F; Unal F; Ozgenc F; Aksu G; Aydogdu S; Kutukculer N; Yagci RV
    J Gastroenterol Hepatol; 2003 Jun; 18(6):645-50. PubMed ID: 12753145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of interferon alfa treatment in Chinese patients with chronic hepatitis B infection: The effect on hepatitis B e antigen seroconversion and the development of cirrhosis-related complications.
    Yuen MF; Hui CK; Cheng CC; Wu CH; Lai YP; Lai CL
    Hepatology; 2001 Jul; 34(1):139-45. PubMed ID: 11431745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of hepatitis B e antigen-negative patients treated with peginterferon α-2a: progressive decrease in hepatitis B surface antigen in responders.
    Rijckborst V; Ferenci P; Akdogan M; Pinarbasi B; ter Borg MJ; Simon K; Flisiak R; Akarca US; Raptopoulou-Gigi M; Verhey E; van Vuuren AJ; Boucher CA; Hansen BE; Janssen HL;
    Eur J Gastroenterol Hepatol; 2012 Sep; 24(9):1012-9. PubMed ID: 22668876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of treatment-related HBsAg loss in HBeAG-negative chronic hepatitis B: a clue from serum HBsAg levels.
    Manesis EK; Hadziyannis ES; Angelopoulou OP; Hadziyannis SJ
    Antivir Ther; 2007; 12(1):73-82. PubMed ID: 17503750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-α2b: relation to response and HBV genotype.
    Sonneveld MJ; Rijckborst V; Cakaloglu Y; Simon K; Heathcote EJ; Tabak F; Mach T; Boucher CA; Hansen BE; Zeuzem S; Janssen HL
    Antivir Ther; 2012; 17(1):9-17. PubMed ID: 22267464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of switching from treatment with nucleos(t)ide analogs to pegylated interferon α-2a on virological and serological responses in chronic hepatitis B patients.
    He LT; Ye XG; Zhou XY
    World J Gastroenterol; 2016 Dec; 22(46):10210-10218. PubMed ID: 28028369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of thymosin alpha-1 and interferon alpha in treatment of chronic viral hepatitis B: a randomized controlled study.
    You J; Zhuang L; Cheng HY; Yan SM; Yu L; Huang JH; Tang BZ; Huang ML; Ma YL; Chongsuvivatwong V; Sriplung H; Geater A; Qiao YW; Wu RX
    World J Gastroenterol; 2006 Nov; 12(41):6715-21. PubMed ID: 17075991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of chronic hepatitis B virus infection in childhood and efficacy of interferon therapy.
    Takano T; Tajiri H; Etani Y; Miyoshi Y; Tanaka Y; Brooks S
    Scand J Gastroenterol; 2015 Jul; 50(7):892-9. PubMed ID: 25861806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot study of combination therapy with ribavirin and interferon alfa for the retreatment of chronic hepatitis B e antibody-positive patients.
    Cotonat T; Quiroga JA; López-Alcorocho JM; Clouet R; Pardo M; Manzarbeitia F; Carreño V
    Hepatology; 2000 Feb; 31(2):502-6. PubMed ID: 10655277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early HBeAg loss during peginterferon alpha-2b therapy predicts HBsAg loss: results of a long-term follow-up study in chronic hepatitis B patients.
    Buster EH; Flink HJ; Simsek H; Heathcote EJ; Sharmila S; Kitis GE; Gerken G; Buti M; de Vries RA; Verhey E; Hansen BE; Janssen HL
    Am J Gastroenterol; 2009 Oct; 104(10):2449-57. PubMed ID: 19584831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B virus genotype B results in better immediate, late and sustained responses to peginterferon-alfa in hepatitis-B-e-antigen-positive patients.
    Chen CH; Lee CM; Hung CH; Wang JH; Hu TH; Changchien CS; Lu SN
    J Gastroenterol Hepatol; 2011 Mar; 26(3):461-8. PubMed ID: 21332543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.